J&J, B+L, Essilor, others fined by Chinese authorities for price fixing

Article

Chinese authorities fined Johnson & Johnson, Baush + Lomb, Essilor International, Nikon, and Carl Zeiss Vision Guangzhou a combined total of 19.6 million yuan, or $3 million, for price fixing in the country’s contact lens and eyeglasses market.

Beijing, China-Chinese authorities finedJohnson & Johnson, Baush + Lomb, Essilor International, Nikon, and Carl Zeiss Vision Guangzhou a combined total of 19.6 million yuan, or $3 million, for price fixing in the country’s contact lens and eyeglasses market. 

A Chinese National Development and Reform Commission (NDRC) investigation found that some of the companies had asked suppliers to sign a contract, which required strict adherence to the manufacturer’s suggested retail price.

According to a statement translated from Chinese, the NDRC said “the companies involved in such acts to limit the distributor’s independent pricing, in violation of the ‘anti-monopoly law,’” and “weaken price competition and undermine the market order of fair competition.” 

Shanghai Weicon Optics and Hoya were also investigated but were not fined because they voluntarily reported monopolistic practices and fixed the problems. 

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.